![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
14 episodes
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
All In Against Cancer Ochsner Cancer Institute
-
- Health & Fitness
-
-
4.9 • 15 Ratings
-
One of the most common complaints we hear from our patients when we first meet them to discuss their cancer diagnosis and treatment plan is that there is a lack of reliable, available information about cancer. Evaluating what is or isn’t a credible source of information on the internet is challenging, even for the most experienced of Googlers. We are seeking to fill that gap by providing the public with understandable, reliable information about cancer.
Join us as we talk to healthcare experts at Ochsner about what you need to know should you or a loved one receive a cancer diagnosis.
-
Episode 14 - Gastric and Esophageal Cancers
Gastric (stomach) and esophageal cancers are common malignancies that affect the first parts of the digestive tract. About 50,000 new cases of gastric and esophageal cancer will be diagnosed each year in the United States.
In this episode of the All In Against Cancer podcast, gastrointestinal medical oncologist Dr. Jonathan Mizrahi talks with Ochsner surgical oncologist, Dr. Nathan Bolton, and surgical oncology nurse practitioner, Jessica Pride, to learn more about the diagnosis, staging and management of patients with gastroesophageal cancers. -
Episode 13 - Bladder Cancer
Bladder cancer is one of the most common cancer diagnoses in the United States. In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Brian Halbert, and Ochsner urologist, Dr. Ro Arcot, about bladder cancer. Tune in to hear more about the approach to diagnosis, staging, treatment and prevention of bladder cancer.
-
Episode 12 - High Risk Breast Cancer Clinic
Breast cancer is the most common cancer diagnosis in women in the United States and currently accounts for the second most cancer deaths in women behind lung cancer. More than 260,000 diagnoses of breast cancer are made each year in this country. Advances in screening techniques and identifying who may be at higher risk for the development of breast cancer has allowed us to provide more targeted screening recommendations for our patients.
In this episode of the All In Against Cancer podcast, we talk with Ochsner breast oncology nurse practitioners Erica Doubleday and Peggy Jo Alker to learn more the importance of and services provided by Ochsner’s high risk breast cancer clinic. -
Episode 11 - Breast Cancer Surgery
Breast cancer is the most common cancer diagnosis in women in the United States and currently accounts for the second most cancer deaths in women behind lung cancer. More than 260,000 diagnoses of breast cancer are made each year in this country, and the majority of these are found at an early enough stage that surgery is a preferred option.
In this episode of the All In Against Cancer podcast, we talk with Ochsner breast surgeon, Dr. Alexa Elder, and plastic surgeon, Dr. Christopher Smith, to learn more about the different types of breast cancer surgeries and how surgical decisions are made in collaboration with patients. -
Episode 10 - Neuroendocrine Tumors
Neuroendocrine tumors represent an uncommon type of cancer that is best managed with a multidisciplinary approach by experts in this disease. There is a wide range of tumor aggressiveness, prognosis, and potential treatment options which largely depends on how the cancer cells appear under the microscope.
In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Lingling Du, and Ochsner interventional radiologist, Dr. Andrew Marsala, about neuroendocrine tumors. Both Dr. Du and Dr. Marsala specialize in the management of neuroendocrine tumors and are members of the Ochsner Neuroendocrine Tumor Team.
Tune in to hear more about the approach to diagnosis and treatment of neuroendocrine tumors. -
Episode 9 - Liver Cancer
Liver cancer is one of the most common types of cancer worldwide and represents the third most common cause of cancer-related death globally. About 75% of liver cancers arise from the liver cells – and these cancers are called hepatocellular carcinoma, or HCC. The majority of the remaining liver cancers arise from the bile ducts that traverse the liver- and these cancers are referred to biliary tract cancers, or cholangiocarcinoma.
In this episode of the All In Against Cancer podcast powered by the Ochsner Cancer Institute, host Dr. Jonathan Mizrahi talks with Ochsner medical oncologist, Dr. Lingling Du, and Ochsner interventional radiologist, Dr. Tyler Sandow, about liver cancer.
Tune in to hear more about the approach to diagnosis, staging, treatment, prevention, and screening for liver cancer.